Sign in

CIK 0001521036

  • Large accelerated filer

Lantheus Holdings, Inc.

Sign in to watch
Ticker
LNTH
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
352318913
Phone
+1 978-671-8001
Business address
201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
Former names
Lantheus MI Holdings, Inc.
  1. 4 Planned sale Director sold 18,373.33 shares at an average $79.19 ($1,454,989)
  2. 4 Planned sale Director sold 2,500 shares at $78.50 ($196,250)
  3. 4 Gift Director gave 2,012 shares (gift)
  4. 4 Shares withheld for taxes See Remarks gave up 1,466 shares (to pay taxes)
  5. 4 Planned sale Chief Accounting Officer sold 341 shares at $76.89 ($26,219)
  6. 4 Shares withheld for taxes Director gave up 629 shares (to pay taxes)
  7. 4 Grant or award Director acquired 2,635 shares (grant or award)
  8. 4 Grant or award Director acquired 2,635 shares (grant or award)
  9. 4 Grant or award Director acquired 2,635 shares (grant or award)
  10. 4 Grant or award Director acquired 2,635 shares (grant or award)
  11. 4 Grant or award Director acquired 2,635 shares (grant or award)
  12. 4 Grant or award Director acquired 2,635 shares (grant or award)
  13. 4 Grant or award Director acquired 2,635 shares (grant or award)
  14. 4 Grant or award Director acquired 2,635 shares (grant or award)
  15. 4 Shares withheld for taxes See Remarks gave up 177 shares (to pay taxes)
  16. 4 Shares withheld for taxes President gave up 455 shares (to pay taxes)
  17. 4 Planned sale Chief Accounting Officer sold 341 shares at $61.24 ($20,883)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Planned sale CFO and Treasurer sold 20,000 shares at $60.00 ($1,200,000)
  20. 4 Planned sale Chief Accounting Officer sold 341 shares at $60.48 ($20,624)

Page 6 of 30 · 598 filings